E-Clinical Solution Software Market Size, Share Global Analysis Report, 2020–2026

Industry Insights

[190+ Pages Report] According to the report published by Facts Factors, the global e-clinical solution software market size was worth around USD 2.4 billion in 2019 and is predicted to grow to around USD 10.9 billion by 2026 with a compound annual growth rate (CAGR) of roughly 13% between 2020 and 2026. The report analyzes the global e-clinical solution software market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the e-clinical solution software market.

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the e-clinical solution software market. The report analyzes and declares the historical and current trends analysis of the e-clinical solution software industry and subsequently recommends the projected trends anticipated to be observed in the e-clinical solution software market during the upcoming years.

The e-clinical solution software market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire-clinical solution software market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the e-clinical solution software market are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the e-clinical solution software market. The report provides an all-inclusive and detailed competitive landscape prevalent in the e-clinical solution software market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the e-clinical solution software market. The e-clinical solution software market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the e-clinical solution software sector. Key strategic developments in e-clinical solution software market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the e-clinical solution software market are appropriately highlighted in the report.

Key Insights from Primary Research        

• As per our primary respondents, the global e-clinical solution software market is set to grow annually at a rate of around 13%, and the revenue was valued at around USD 2.4 Billion in 2019.
• North America held the largest market share in 2019due to the rise in preference for advancement in technology by the organizations and institutes.
• On basis of the “Product” segment, the randomization and trial supply management segment dominated the global e-clinical solution software market due to the rise in pharmaceutical companies for a clinical trials of drugs.
• On basis of the “End-User” segment, the clinical research organizations segment dominated the global e-clinical solution software market because it is widely used in this industry for the production of new drugs.
• The presence of well-established players has intensified the industry rivalry, due to which the degree of competition is considerably higher.

Key Recommendations from Analysts

• As per our analysts, the global e-clinical solution software market is expected to grow significantly over the forecast period due to the high demand for the production of new drugs by the use of clinical trials.
• As per analysts, the high growth in the healthcare sector is boosting the market.
• The collaborations and partnerships between the manufacturing firms can create lucrative opportunities worldwide.
• Our team of analysts has identified, that North America is expected to be the fastest-growing market over the estimated period, as the medical tourism industry has emerged in this region.

The global e-clinical solution software market is experiencing significant growth that is expected to continue over the upcoming years. Also, the high demand for the production of new drugs by the use of clinical trials and research and development activities is expected to boost the demand for the e-clinical solution software market globally. The market is also growing because of the increase in the need for efficient data management and also standardization of the data.

The e-clinical solution software market research report delivers an acutevaluationand taxonomy of the e-clinical solution software industry by practically splitting the market on the basis of different products, delivery modes, clinical trials, end-users, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026.

Report Scope

The regional segmentation of the e-clinical solution software industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the 3D scanner industry is provided for the leading economies of the world.

The e-clinical solution software market is segmented based on the product, delivery mode, clinical trials, end-user, and region. On the basis of product, the market is classified into electronic trial master files, electronic data capture and clinical data management systems, clinical outcome assessment, clinical analytics platform, randomization, and trial supply management, clinical data integration platform, regulatory information management solutions, safety solutions, and others.

On the basis of delivery mode segmentation, the market is classified into the licensed enterprise, web-hosted, and cloud-based. On the basis of clinical trials, the market is segmented into phases I, II, III, IV. In terms of end-user segmentation, the market is bifurcated into contract research organizations, medical device manufacturers, academic research institutions, pharmaceutical, and biopharmaceutical companies, consulting service companies, and hospitals.

Major key players operating in the e-clinical solution software market include

• Medidata Solutions Inc
• Merge Healthcare Incorporated
• BioClinica Inc.
• Bio-Optronics Inc.
• DATATRAK International
• ERT
• MaxisIT Inc.
• CRF Health
• eClinical Solutions Inc.
• PAREXEL International Corporation
• OmniComm Systems Inc. 

The taxonomy of the e-clinical solution software market by its scope and segmentation is as follows:

Product Analysis

• Electronic Trail Master Files
• Electronic Data Capture and Clinical Data Management Systems
• Clinical Outcome Assessment
• Clinical Analytics Platform
• Randomization and Trial Supply Management
• Clinical Data Integration Platform
• Regulatory Information Management Solutions
• Safety Solutions
• Others

Delivery Mode Analysis

• Licensed Enterprise
• Web Hosted
• Cloud Based

Clinical Trials Analysis

• Phase I
• Phase II
• Phase III
• Phase IV

End-UserAnalysis

• Contract Research Organizations
• Medical Device Manufacturers
• Academic Research Institutions
• Pharmaceutical and Biopharmaceutical Companies
• Consulting Service Companies
• Hospitals

Regional Segmentation Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa